Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR6A1 |
| Upstream (Parents) |
|---|
| (<<) ASCL2 → NR6A1 |
| (<<) CDX2 → NR6A1 |
| (<<) PITX1 → NR6A1 |
| (<<) OVOL1 → NR6A1 |
| (<<) SOX9 → NR6A1 |
| (<<) TFCP2L1 → NR6A1 |
| (<<) BACH2 → NR6A1 |
| (<<) NR3C1 → NR6A1 |
| (<<) SNAI2 → NR6A1 |
| (<<) FLI1 → NR6A1 |
| (<<) ELF3 → NR6A1 |
| (<<) ZFHX4 → NR6A1 |
| (<<) PLAGL2 → NR6A1 |
| (<<) TCF7 → NR6A1 |
| (<<) HOXB5 → NR6A1 |
| (<<) NR2F2 → NR6A1 |
| (<<) ELF1 → NR6A1 |
| Downstream (Children) |
|---|
| NR6A1 → SLC26A3 (>>) |
| NR6A1 → HIC1 (>>) |
| NR6A1 → RFXAP (>>) |
| NR6A1 → ZHX3 (>>) |
| NR6A1 → ATF6B (>>) |
| NR6A1 → FEV (>>) |
| NR6A1 → MYCL1 (>>) |
